Biphasic dynamics of beta cell mass in a mouse model of congenital hyperinsulinism: implications for type 2 diabetes
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biphasic dynamics of beta cell mass in a mouse model of congenital hyperinsulinism: implications for type 2 diabetes
Authors
Keywords
-
Journal
DIABETOLOGIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-10
DOI
10.1007/s00125-021-05390-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inadequate β-cell mass is essential for the pathogenesis of type 2 diabetes
- (2020) Gordon C Weir et al. Lancet Diabetes & Endocrinology
- Beta cell identity changes with mild hyperglycemia: Implications for function, growth, and vulnerability
- (2020) Aref G. Ebrahimi et al. Molecular Metabolism
- β-cell secretory dysfunction: a key cause of type 2 diabetes – Authors' reply
- (2020) Gordon C Weir et al. Lancet Diabetes & Endocrinology
- β-cell secretory dysfunction: a key cause of type 2 diabetes
- (2020) Rury R Holman et al. Lancet Diabetes & Endocrinology
- Single cell transcriptomics of human islet ontogeny defines the molecular basis of β cell dedifferentiation in T2D
- (2020) Dana Avrahami et al. Molecular Metabolism
- Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes
- (2019) Peter J. Thompson et al. Cell Metabolism
- Acceleration of β Cell Aging Determines Diabetes and Senolysis Improves Disease Outcomes
- (2019) Cristina Aguayo-Mazzucato et al. Cell Metabolism
- Resealable, optically accessible, PDMS-free fluidic platform for ex vivo interrogation of pancreatic islets
- (2017) Giovanni Lenguito et al. LAB ON A CHIP
- Islet cells share promoter hypomethylation independently of expression, but exhibit cell-type–specific methylation in enhancers
- (2017) Daniel Neiman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Insights into the role of neuronal glucokinase
- (2016) Ivan De Backer et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- A Mathematical Model of the Pathogenesis, Prevention, and Reversal of Type 2 Diabetes
- (2016) Joon Ha et al. ENDOCRINOLOGY
- Insulin demand regulates β cell number via the unfolded protein response
- (2015) Rohit B. Sharma et al. JOURNAL OF CLINICAL INVESTIGATION
- Type 2 Diabetes and Congenital Hyperinsulinism Cause DNA Double-Strand Breaks and p53 Activity in β Cells
- (2013) Sharona Tornovsky-Babeay et al. Cell Metabolism
- Dose-ranging study with the glucokinase activator AZD1656 in patients with type 2 diabetes mellitus on metformin
- (2013) J. P. H. Wilding et al. DIABETES OBESITY & METABOLISM
- Endoplasmic Reticulum Stress and Type 2 Diabetes
- (2012) Sung Hoon Back et al. Annual Review of Biochemistry
- Control of Pancreatic β Cell Regeneration by Glucose Metabolism
- (2011) Shay Porat et al. Cell Metabolism
- Effects of MK-0941, a Novel Glucokinase Activator, on Glycemic Control in Insulin-Treated Patients With Type 2 Diabetes
- (2011) G. E. Meininger et al. DIABETES CARE
- Endoplasmic reticulum stress and pancreatic β-cell death
- (2011) Sonya G. Fonseca et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Conditional Gene Targeting in Mouse Pancreatic -Cells: Analysis of Ectopic Cre Transgene Expression in the Brain
- (2010) B. Wicksteed et al. DIABETES
- Brain expression of Cre recombinase driven by pancreas-specific promoters
- (2010) Junghun Song et al. GENESIS
- Large Islets, Beta-Cell Proliferation, and a Glucokinase Mutation
- (2010) Sameer Kassem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extremes of Clinical and Enzymatic Phenotypes in Children With Hyperinsulinism Caused by Glucokinase Activating Mutations
- (2009) S. Sayed et al. DIABETES
- Advanced Glycation End Products Inhibit Glucose-Stimulated Insulin Secretion through Nitric Oxide-Dependent Inhibition of CytochromecOxidase and Adenosine Triphosphate Synthesis
- (2009) Zhengshan Zhao et al. ENDOCRINOLOGY
- Assessing the potential of glucokinase activators in diabetes therapy
- (2009) Franz M. Matschinsky NATURE REVIEWS DRUG DISCOVERY
- Long-Term Follow-Up of Oral Glucose Tolerance Test-Derived Glucose Tolerance and Insulin Secretion and Insulin Sensitivity Indexes in Subjects With Glucokinase Mutations (MODY2)
- (2008) D. Martin et al. DIABETES CARE
- Initiation and execution of lipotoxic ER stress in pancreatic -cells
- (2008) D. A. Cunha et al. JOURNAL OF CELL SCIENCE
- Chop deletion reduces oxidative stress, improves β cell function, and promotes cell survival in multiple mouse models of diabetes
- (2008) Benbo Song et al. JOURNAL OF CLINICAL INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now